The antibacterial activity of extracts of nine plant species with good activity against Escherichia coli against five other bacteria and cytotoxicity of extracts

Ishaku Leo Elisha,Francien S. Botha,Lyndy Joy McGaw,Jacobus Nicolaas Eloff

DOI: https://doi.org/10.1186/s12906-017-1645-z

IF: 4.782

2017-02-28

BMC Complementary and Alternative Medicine

Abstract:BackgroundThe development of antibiotic resistant bacteria stems from a number of factors, including inappropriate use of antibiotics in human and animal health and their prolonged use as growth promoters at sub-clinical doses in poultry and livestock production. We were interested in investigating plants that could be useful in protecting humans or animals against diarrhoea. We decided to work on extracts of nine plant species with good activity against Escherichia coli based on earlier work in the Phytomedicine Programme. Leaves of nine medicinal plant species with high antibacterial activity against Escherichia coli were extracted with acetone and their minimal inhibitory concentration (MIC) values determined using a microplate serial dilution technique against Gram-positive (Staphylococcus aureus, Enterococcus faecalis and Bacillus cereus) and Gram-negative (Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa) bacteria. Bioautography was used to determine the number of bioactive compounds in each extract. In vitro safety of the extracts was determined using the 3-(4,5-dimethylthiazolyl-2)-2,5-diphenyltetrazolium bromide reduction assay on Vero cells.ResultsThe extracts were active against all the pathogens with average MICs ranging from 0.02 to 0.52 mg/ml. As expected E. coli was relatively sensitive, while E. faecalis and S. Typhimurium were more resistant to the extracts (average MICs of 0.28 mg/ml and 0.22 mg/ml respectively). Cremaspora triflora and Maesa lanceolata leaf extracts had higher activity than the other extracts against Gram-positive and Gram-negative pathogens with mean MICs of 0.07 mg/ml and 0.09 mg/ml respectively. Extracts of Maesa lanceolata and Hypericum roeperianum had the highest total antibacterial activity (TAA) at 1417 and 963 ml/g respectively. All extracts with the exception of that of Maesa lanceolata, Elaeodendron croceum and Calpurnia aurea had relatively low cytotoxicity with LC50 > 20 μg/ml. Cremaspora triflora had the best selectivity index (SI) against S. aureus and E. coli of 2.87 and 1.15 respectively. Hypericum roeperianum had a SI of 1.10 against B. cereus. Bioautography revealed 1–6 visible antimicrobial compounds that were generally non-polar.ConclusionsThere was a weak positive, but statistically non-significant correlation between the potency of the extracts and their cytotoxicity (R = 0.45, ρ > 0.05). The activity of the extracts on the test bacteria was in some cases not correlated with cytotoxicity, as shown by selectivity indices >1. This means that cellular toxicity was probably not due to compounds with antibacterial activity. Some of the extracts had a good potential for therapeutic use against the bacterial pathogens or for application in treating diarhoea. It does not appear that activity against E. coli is a good predictor of activity against Gram-negative rather than Gram-positive bacteria. Further investigation is in progress on C. triflora and H. roeperianum, both of which had promising activities and potential safety based on cytotoxicity.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop new antibacterial drugs to deal with the increasingly serious problem of antibiotic resistance. Specifically, the researchers studied the antibacterial activities of nine plant extracts, which had shown good antibacterial activities against Escherichia coli in previous studies. The main objectives of the study include:

1. **Evaluating antibacterial activity**: Determine the antibacterial activities of these nine plant extracts against five other bacteria (including Staphylococcus aureus, Enterococcus faecalis, Bacillus cereus, Salmonella Typhimurium and Pseudomonas aeruginosa) as measured by the minimum inhibitory concentration (MIC).

2. **Analyzing cytotoxicity**: Evaluate the cytotoxicity of these plant extracts on Vero monkey kidney cells using the MTT reduction assay to ensure their safety.

3. **Exploring active compounds**: Determine the number of active compounds in each extract and their polarity characteristics by bioautography.

4. **Evaluating the selectivity index**: Calculate the selectivity index (SI), which is the ratio of the cytotoxic half - lethal concentration (LC50) to the minimum inhibitory concentration (MIC), to evaluate the therapeutic potential of the extracts.

Through these studies, the authors hope to find plant extracts that are both effective and safe for the treatment of infections caused by these bacteria, especially diarrhea. In addition, the study also explored the differences in the activities of the extracts against Gram - negative and Gram - positive bacteria, and whether such differences can be used as an indicator for screening potential antibacterial drugs.